Missouri Funds Psilocybin Research for Opioid Addiction Treatment with $5 Million
• Missouri allocates $5 million from its opioid settlement fund to research psilocybin's potential in treating opioid use disorders and reducing overdose deaths.
• The Department of Mental Health seeks expert input to develop competitive grants for psilocybin-related opioid research projects.
• The initiative follows HB 2010, initially considering ibogaine but later focusing on psilocybin for opioid addiction treatment research.
• Researchers are invited to provide feedback on how psilocybin research would be conducted, its duration, and its alignment with national opioid settlement guidelines.
© Copyright 2025. All Rights Reserved by MedPath